Assessment of nanotoxicity in a human placenta-on-a-chip from trophoblast stem cells

• Published in: Ecotoxicology and environmental safety Vol. 285; p. 117051
• Main Authors: Cao, Rongkai, Guo, Yuxin, Liu, Jiayue, Guo, Yaqiong, Li, Xiang, Xie, Fuwei, Wang, Yaqing, Qin, Jianhua
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Inc 15-10-2024; Elsevier
• Subjects: Copper oxide nanoparticles; Human trophoblast stem cells; Nanotoxicity; Organ-on-a-chip; Placental barrier; Nanotoxicity; Organ-on-a-chip; Human trophoblast stem cells; Placental barrier; Copper oxide nanoparticles
• ISSN: 0147-6513; 1090-2414; 1090-2414
• DOI: 10.1016/j.ecoenv.2024.117051

Maternal exposure to nanoparticles during gestation poses potential risks to fetal development. The placenta, serving as a vital interface for maternal-fetal interaction, plays a pivotal role in shielding the fetus from direct nanoparticle exposure. However, the impact of nanoparticles on placental function is still poorly understood, primarily due to the absence of proper human placental models. In this study, we established a placenta-on-a-chip model capable of recapitulating nanoparticle exposure to assess potential nanotoxicity. The model was assembled by coculturing human trophoblast stem cells (hTSCs) and endothelial cells within a dynamic microsystem. hTSCs exhibited progressive differentiation into syncytiotrophoblasts under continuous fluid flow, forming a bilayered trophoblastic epithelium that mimicking both structural and functional aspects of human placental villi. Copper oxide nanoparticles (CuO NPs) were introduced into the trophoblastic side to simulate maternal blood exposure. Our findings revealed that CuO NPs hindered hTSCs differentiation, leading to diminished hormone secretion and impaired glucose transport. Subsequent analysis indicated that CuO NPs disrupted the autophagic flux in trophoblasts and induced apoptosis. Furthermore, the placenta-on-a-chip model exhibited inflammatory responses to CuO NP exposure, including maternal macrophage activation, inflammatory cytokine secretion, and endothelial barrier disruption. Dysfunction of the placental barrier and the ensuing inflammatory cascades may contribute to aberrant fetal development. Overall, our placenta-on-a-chip model offers a promising platform for assessing nanoparticle exposure-related risks and conducting toxicology studies.
[Display omitted]